Sequenta (fka MLC Dx)

Molecular diagnostic assays that will enable new paradigms in the treatment of diseases as diverse as infection, auto-immune disease, and cancer.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Sequenta (fka MLC Dx) plus 5857 other startups.

Learn More

Learn More About Sequenta (fka MLC Dx)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More

Companies We Work With